Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes
Yurong Song, Chenxi Li, Guangzhi Liu, et al.
Clinical Pharmacokinetics (2021) Vol. 60, Iss. 5, pp. 585-601
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 73
Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review
Basma Hossam Abdelmonem, Noha M. Abdelaal, Eman K. E. Anwer, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1467-1467
Open Access | Times Cited: 16
Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13302-13302
Open Access | Times Cited: 44
Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes
Jing Jin, Xiao‐bo Zhong
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 6, pp. 672-684
Open Access | Times Cited: 16
A Cytochrome P450 AaCP1 Is Required for Conidiation and Pathogenicity in the Tangerine Pathotype of Alternaria alternata
Huilan Fu, Wenge Li, Jintian Tang
Microorganisms (2025) Vol. 13, Iss. 2, pp. 343-343
Open Access
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors
Marco Calabrò, Chiara Fabbri, Alessandro Serretti, et al.
Psychiatric Genetics (2025)
Closed Access
The key role of cytochrome P450s in the biosynthesis of plant derived natural products
Yawen Zhao, Zhenzhen Wu, Jiayao Li, et al.
Plant Physiology and Biochemistry (2025) Vol. 222, pp. 109695-109695
Closed Access
Cytochrome P450 monooxygenase systems: diversity and plasticity for adaptive stress response
Innokenty M. Mokhosoev, Dmitry V. Astakhov, Alexander A. Terentiev, et al.
Progress in Biophysics and Molecular Biology (2024) Vol. 193, pp. 19-34
Closed Access | Times Cited: 4
Liver Damage and microRNAs: An Update
Erika Cione, Diana Marisol Abrego-Guandique, Maria Cristina Caroleo, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 78-91
Open Access | Times Cited: 20
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting
Camille Lenoir, Jean Terrier, Yvonne Gloor, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 526-526
Open Access | Times Cited: 18
The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice
Yan Zhu, Li Chen, Yuqi He, et al.
Drug Metabolism Reviews (2023) Vol. 55, Iss. 3, pp. 163-180
Open Access | Times Cited: 11
Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study
Marco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
European Neuropsychopharmacology (2022) Vol. 56, pp. 100-111
Closed Access | Times Cited: 14
Drug metabolism
Lesley A. Stanley
Elsevier eBooks (2023), pp. 597-624
Closed Access | Times Cited: 8
Identifying genetic variants associated with side effects of antidepressant treatment: A systematic review
Gabriel Zurchimitten, Laísa Camerini, Geison Souza Izídio, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111154-111154
Closed Access | Times Cited: 2
Insight into the corrosion inhibiting potential and anticancer activity of 1-(4-methoxyphenyl)-5-methyl-N’-(2-oxoindolin-3-ylidene)-1H-1,2,3-triazole-4-carbohydrazide via computational approaches
Oluwatoba Emmanuel Oyeneyin, Abdulwasiu Ibrahim, Nureni Ipinloju, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 20, pp. 11149-11166
Open Access | Times Cited: 7
Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
Yue Xu, Tao Tao, Yong Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Evolutionary conservation analysis of human arachidonic acid metabolism pathway genes
Cengfan Wei, Meng Wang, Xiu‐Jie Wang
Life Medicine (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 6
Amoxicillin-Clavulanate Induced Liver Injury in a Young Female
Jennifer Appiah, Ankita Prasad, Viraj Shah, et al.
Cureus (2023)
Open Access | Times Cited: 5
Human Liver Organoid Models for Assessment of Drug Toxicity at the Preclinical Stage
Mustafa Karabicici, Soheil Akbari, Özge Ertem, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 23, Iss. 14, pp. 1713-1724
Closed Access | Times Cited: 5
Do the Effects of Krebs Cycle Intermediates on Oxygen-Dependent Processes in Hypoxia Mediated by the Nitric Oxide System Have Reciprocal or Competitive Relationships?
Natalia Kurhaluk, Олександр Лукаш, Halina Tkaczenko
Cellular Physiology and Biochemistry (2023) Vol. 57, Iss. 6, pp. 426-451
Open Access | Times Cited: 5
Computational 3D Modeling-Based Identification of Inhibitors Targeting Cysteine Covalent Bond Catalysts for JAK3 and CYP3A4 Enzymes in the Treatment of Rheumatoid Arthritis
Abdelmoujoud Faris, Radwan Alnajjar, Jingjing Guo, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 23-23
Open Access | Times Cited: 5
Drug-Induced Liver Injury
Cathy McAtee
Critical Care Nursing Clinics of North America (2022) Vol. 34, Iss. 3, pp. 267-275
Closed Access | Times Cited: 9
Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management
Isabely Mayara da Silva, Beatriz Geovana Leite Vacario, Nádia Calvo Martins Okuyama, et al.
Gene (2024) Vol. 907, pp. 148252-148252
Closed Access | Times Cited: 1
A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
Y. Jiang, Ye-Ming Cao, Yongbing Cao, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 1511-1521
Open Access | Times Cited: 1
The Use of Microdosing for In vivo Phenotyping of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review
Lisa T. van der Heijden, Frans L. Opdam, Jos H. Beijnen, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 4, pp. 407-418
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top